Securities and Exchange Board of India
Securities and Exchange Board of India (SEBI) is the regulator for the securities market in India. Established in 1988, it was given statutory powers on 30 January 1992 through the SEBI Act, 1992. Its primary functions include protecting investor interests, promoting and regulating the Indian securities markets. SEBI is responsive to the needs of three groups, which constitute the market: the issuers of securities, the investors, and the market intermediaries. It has been mandated to create a fair and efficient securities market in the country and also to prevent any frauds or malpractices within the securities market.
History
The need for SEBI was identified in the 1980s when the Indian stock market was hit by a major scam involving the diversion of funds. To address this, the Government of India established SEBI in 1988 through an executive resolution, and it was given statutory powers with the passing of the SEBI Act in 1992.
Functions
SEBI has been vested with a wide range of powers and functions to meet its objectives. These include:
- Regulating the business in stock exchanges and any other securities markets
- Registering and regulating the work of stock brokers, sub-brokers, share transfer agents, bankers to an issue, trustees of trust deeds, registrars to an issue, merchant bankers, underwriters, portfolio managers, investment advisers and such other intermediaries who may be associated with securities markets in any manner
- Registering and regulating the working of collective investment schemes, including mutual funds
- Promoting and regulating self-regulatory organizations
- Prohibiting fraudulent and unfair trade practices relating to securities markets
- Promoting investors' education and training of intermediaries of securities markets
- Prohibiting insider trading in securities
- Regulating substantial acquisition of shares and takeover of companies
- Performing such functions and exercising such powers under the provisions of the Securities Contracts (Regulation) Act, 1956, as may be delegated to it by the Central Government
Structure
SEBI is headed by a Chairman who is appointed by the Government of India. It has several departments managed by department heads, focusing on different aspects of the securities market, including corporate finance, trading, market regulation, investment management, and research and analysis.
Regulatory Framework
SEBI has formulated several regulations, rules, and guidelines to protect the interests of investors and to regulate the securities market. This includes the SEBI (Issue of Capital and Disclosure Requirements) Regulations, SEBI (Listing Obligations and Disclosure Requirements) Regulations, and SEBI (Prohibition of Insider Trading) Regulations, among others.
Recent Initiatives
SEBI has been proactive in its approach to dealing with challenges in the securities market. It has introduced measures to strengthen corporate governance, increase transparency, and improve the overall market structure. This includes tightening of disclosure norms, introduction of corporate governance guidelines, and measures to curb insider trading.
Challenges
Despite its efforts, SEBI faces challenges in terms of ensuring compliance with its regulations, dealing with high-profile cases of market manipulation, and adapting to the rapidly changing landscape of the global securities market.
Conclusion
The Securities and Exchange Board of India plays a crucial role in the development and regulation of the securities market in India. Its efforts towards ensuring investor protection, market integrity, and the development of a robust securities market infrastructure are vital for the economic development of the country.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD